Transition Bio is a company that uses its Condensomics platform to develop technologies for biomolecular condensate analysis. They use droplet microfluidic approaches and cellular platforms to map and modulate condensates with precision. Their proprietary datasets feed into algorithms for target discovery, validation, and drug design.